Recursion Pharmaceuticals Inc - Ordinary Shares - Class A - RXRX - stock price prediction, stock price target, analyst ratings from 8 analysts

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A has a share price target of US$ 7, revenue growth forecast of 20.6%, and profit growth estimate of -14.6% for FY25, based on top 8 analyst calls.